Grow your business safely with DEVELOPPEMENT PHARMA

All the information you need about DEVELOPPEMENT PHARMA to develop and secure your business in France

D HOME > CORPORATES > DEVELOPPEMENT PHARMA > BALANCE SHEET ( 2023-02-14)

THE LIST OF BALANCE SHEET : DEVELOPPEMENT PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2023-02-14 Public 2022-05-31 Complete
NameDEVELOPPEMENT PHARMA
Siren908526676
Closing2022-05-31
Registry code 4901
Registration number 1388
Management number2021D01924
Activity code 6430Z
Closing date n-11901-01-01
Duration Fiscal year 05
Duration Fiscal year n-100
Filing date2023-02-14
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address49100 ANGERS
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BJ TOTAL (I) 8 931 320.00 8 931 320.00 8 931 320.00
BZ Other receivables 237 710.00 237 710.00 237 710.00
CF Cash and cash equivalents 22 022.00 22 022.00 22 022.00
CJ TOTAL (II) 259 732.00 259 732.00 259 732.00
CO Grand total (0 to V) 9 191 052.00 9 191 052.00 9 191 052.00
CU Other investments 8 931 320.00 8 931 320.00 8 931 320.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 8 921 000.00 8 921 000.00
DI RESULTS FOR THE YEAR (Profit or Loss) 227 831.00 227 831.00
DK Regulated provisions 912.00 912.00
DL TOTAL (I) 9 149 743.00 9 149 743.00
DV Miscellaneous Loans and Financial Debts (4) 30 000.00 30 000.00
DX Trade payables and related accounts 10 955.00 10 955.00
DY Tax and social security liabilities 354.00 354.00
EC TOTAL (IV) 41 309.00 41 309.00
EE Grand total (I to V) 9 191 052.00 9 191 052.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FW Other purchases and external expenses 8 613.00
GF Total Operating Expenses (II) 8 613.00
GG - OPERATING RESULT (I - II) -8 613.00
GJ Financial income from other securities and fixed asset receivables 237 710.00
GP Total financial income (V) 237 710.00
GV - FINANCIAL INCOME (V - VI) 237 710.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 229 097.00
4 - Income statement (continued)Amount year NAmount year N-1
HG Exceptional depreciation and provisions 912.00 912.00
HH Total exceptional expenses (VIII) 912.00 912.00
HI - EXCEPTIONAL RESULT (VII - VIII) -912.00 -912.00
HK Income tax 354.00 354.00
HL TOTAL REVENUE (I + III + V + VII) 237 710.00 237 710.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 9 879.00 9 879.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 227 831.00 227 831.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 8 931 320.00
I3 DECREASES Total Financial Fixed Assets 8 931 320.00
I4 DECREASES Grand Total 8 931 320.00
LQ ACQUISITIONS Total Financial Fixed Assets 8 931 320.00
7 - Provisions Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
3X Extraordinary depreciation
3Z Total regulated provisions 912.00
7C Grand total 912.00
UJ - Exceptional 912.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 10 955.00 10 955.00 10 955.00
8E Income Taxes 354.00 354.00 354.00
VI Group and Associates 30 000.00 30 000.00 30 000.00
VR Miscellaneous debtors (including receivables related to repo transactions) 237 710.00 237 710.00 237 710.00
VT TOTAL – STATEMENT OF RECEIVABLES 237 710.00 237 710.00 237 710.00
VY TOTAL – STATEMENT OF LIABILITIES 41 309.00 41 309.00 41 309.00

all companies in France

Complete and comprehensive database.